Trial Profile
A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Coadministered With Fenofibrate in Subjects With Combined Hyperlipidemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lapaquistat (Primary) ; Fenofibrate
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 31 Dec 2008 New trial record.